scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1019143971 |
P356 | DOI | 10.1186/AR4317 |
P8608 | Fatcat ID | release_jgjluhud7jfgrj5dwmu3fqljsi |
P932 | PMC publication ID | 3978433 |
P698 | PubMed publication ID | 24286492 |
P5875 | ResearchGate publication ID | 259001860 |
P50 | author | Ranjeny Thomas | Q38523203 |
Mihir D Wechalekar | Q38523254 | ||
P2093 | author name string | Malcolm Smith | |
Jane Goodall | |||
Oliver FitzGerald | |||
Hill Gaston | |||
Helen Benham | |||
Paul Norris | |||
Agnes Szentpetery | |||
P2860 | cites work | Circulating Th17, Th22, and Th1 cells are increased in psoriasis | Q24629315 |
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants | Q24646663 | ||
Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis | Q24674100 | ||
Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris | Q24676186 | ||
Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis | Q28246778 | ||
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells | Q33869215 | ||
Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis | Q33941199 | ||
IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates | Q34009808 | ||
Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. | Q34478064 | ||
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics | Q34771528 | ||
Prevalence of joint disease in patients with psoriasis: implications for therapy | Q35157479 | ||
Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. | Q36229199 | ||
IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation | Q36383605 | ||
The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints | Q36907683 | ||
Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium | Q37207081 | ||
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. | Q37298535 | ||
New insights into the pathogenesis and genetics of psoriatic arthritis | Q37381676 | ||
Breaking old paradigms: Th17 cells in autoimmune arthritis | Q37464427 | ||
Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy | Q37866683 | ||
Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells | Q43991749 | ||
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. | Q45939390 | ||
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells | Q46043893 | ||
Frequency and phenotype of T helper 17 cells in peripheral blood and synovial fluid of patients with reactive arthritis. | Q46137644 | ||
Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial | Q46397390 | ||
Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis | Q49143365 | ||
Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. | Q50485305 | ||
Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. | Q51795770 | ||
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. | Q52911182 | ||
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. | Q53660636 | ||
Psoriasis | Q56115292 | ||
β-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice | Q57116531 | ||
A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses | Q60035686 | ||
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells | Q60683094 | ||
A role for T cell-derived interleukin 22 in psoriatic skin inflammation | Q62662121 | ||
Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis | Q71781127 | ||
Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis | Q73582844 | ||
Classification criteria for psoriatic arthritis: development of new criteria from a large international study | Q80001900 | ||
Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases | Q80510869 | ||
Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides | Q81722146 | ||
Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients | Q82133148 | ||
Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts | Q82240437 | ||
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis | Q83163682 | ||
Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage | Q84328066 | ||
Role of Th17 cells in human autoimmune arthritis | Q84488292 | ||
P433 | issue | 5 | |
P921 | main subject | psoriatic arthritis | Q511097 |
P304 | page(s) | R136 | |
P577 | publication date | 2013-09-26 | |
P1433 | published in | Arthritis Research and Therapy | Q15757229 |
P1476 | title | Th17 and Th22 cells in psoriatic arthritis and psoriasis | |
P478 | volume | 15 |
Q50034717 | "STATus of STAT3 in Psoriatic Arthritis." |
Q55332265 | A catalog of potential putative functional variants in psoriasis genome-wide association regions. |
Q56891106 | Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives |
Q64277648 | Advances in Understanding the Immunological Pathways in Psoriasis |
Q47108321 | Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis. |
Q47734526 | Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions |
Q47962744 | Apremilast in psoriasis - a prospective real-world study. |
Q50034719 | Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis. |
Q38753752 | Biological and pathological activities of interleukin-22. |
Q38248904 | Biomarkers in psoriatic arthritis: recent progress |
Q87600788 | C-reactive protein gene and Toll-like receptor 4 gene polymorphisms can relate to the development of psoriatic arthritis |
Q45795234 | CD4 T-Cell Dysregulation in Psoriatic Arthritis Reveals a Regulatory Role for IL-22. |
Q35885484 | COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis |
Q48203983 | CXCL4 is a novel inducer of human Th17 cells and correlates with IL-17 and IL-22 in psoriatic arthritis |
Q92422137 | Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review |
Q33710131 | Changes of circulating Th22 cells in children with hand, foot, and mouth disease caused by enterovirus 71 infection |
Q38601424 | Cytokine and Chemokines Alterations in the Endemic Form of Pemphigus Foliaceus (Fogo Selvagem). |
Q54979857 | Distinct In Vitro T-Helper 17 Differentiation Capacity of Peripheral Naive T Cells in Rheumatoid and Psoriatic Arthritis. |
Q42568263 | Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis |
Q50268454 | Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases |
Q41449533 | Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis |
Q47376394 | Elevated IL-17A and IL-22 regulate expression of inducible CD38 and Zap-70 in chronic lymphocytic leukemia. |
Q40924512 | Expression of interleukin-17 in lesions of erythema multiforme may indicate a role for T helper 17 cells |
Q34937925 | Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy? |
Q61651896 | IL-17 in the immunopathogenesis of spondyloarthritis |
Q35005069 | IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis |
Q90281753 | Identification of myeloid cells in the human enthesis as the main source of local IL-23 production |
Q51603409 | Immunophenotyping of T cells in the peripheral circulation in psoriasis. |
Q47704613 | Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities |
Q38615132 | JAK2/STAT3 Pathway Was Associated with the Protective Effects of IL-22 On Aortic Dissection with Acute Lung Injury. |
Q64248277 | Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16 Cell Subsets |
Q89427856 | Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis |
Q92856727 | Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis |
Q64941766 | Naturally derived Heme-Oxygenase 1 inducers attenuate inflammatory responses in human dendritic cells and T cells: relevance for psoriasis treatment. |
Q38799600 | New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis |
Q40436128 | Non-redundant roles for Th17 and Th22 cells in multiple myeloma clinical correlates. |
Q41460287 | Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris |
Q96134668 | Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances |
Q91975345 | Pemphigus foliaceus patients (Fogo Selvagem) treated with kinesiotherapy presented lower levels of proinflammatory cytokines |
Q39084926 | Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints |
Q51690338 | Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells. |
Q50099588 | Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints |
Q38864743 | Secukinumab: A Review in Psoriatic Arthritis |
Q92802233 | Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study) |
Q28080245 | Soluble fibrinogen like protein 2 (sFGL2), the novel effector molecule for immunoregulation |
Q55512008 | T Cell Hierarchy in the Pathogenesis of Psoriasis and Associated Cardiovascular Comorbidities. |
Q28069848 | T Helper Cell Subsets in Clinical Manifestations of Psoriasis |
Q38548745 | T-helper 22 cells as a new player in chronic inflammatory skin disorders. |
Q38664951 | Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis |
Q36151179 | Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi |
Q34432491 | Th17 Cells Coordinate with Th22 Cells in Maintaining Homeostasis of Intestinal Tissues and both are Depleted in SIV-Infected Macaques |
Q39228029 | Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life |
Q21284677 | Th17 cells in autoimmune and infectious diseases |
Q92454295 | Th17 cells increase during maturation in peripheral blood of healthy dogs |
Q38815070 | The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis |
Q90207982 | The Contribution of PTPN22 to Rheumatic Disease |
Q28252101 | The IL-20 subfamily of cytokines--from host defence to tissue homeostasis |
Q38439641 | The IL-23-IL-17 axis in inflammatory arthritis |
Q26799454 | The Newly Identified T Helper 22 Cells Lodge in Leukemia |
Q35592370 | The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic myeloid leukemia |
Q40800458 | The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis |
Q38182899 | The microbiome and psoriatic arthritis |
Q96304966 | The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2 |
Q59040804 | The pathogenesis of psoriatic arthritis |
Q37143988 | The relationship between body mass index, waist circumference and psoriatic arthritis in the Turkish population |
Q39328684 | The role of IL-12/23 in T cell-related chronic inflammation: implications of immunodeficiency and therapeutic blockade |
Q48283709 | The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling |
Q61649466 | Transcriptional network profile on synovial fluid T cells in psoriatic arthritis |
Q54194408 | Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice. |
Q48086737 | Ustekinumab for the treatment of psoriatic arthritis. |
Q34047769 | Utility of arthroscopic guided synovial biopsy in understanding synovial tissue pathology in health and disease states |
Q55339808 | Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis. |